老年高血压合并认知障碍诊疗中国专家共识(2021 版)

2021-04-25 中国老年医学学会 中国心血管杂志.2021.26(2):101-111.

为减少老年高血压合并认知障碍的风险,中国老年医学学会、中国老年医学学会高血压分会和认知障碍分会、国家老年疾病临床医学研究中心(解放军总医院)、国家老年疾病临床医学研究中心-老年心血管病防治联盟联合邀请

中文标题:

老年高血压合并认知障碍诊疗中国专家共识(2021 版)

发布机构:

中国老年医学学会

发布日期:

2021-04-25

简要介绍:

为减少老年高血压合并认知障碍的风险,中国老年医学学会、中国老年医学学会高血压分会和认知障碍分会、国家老年疾病临床医学研究中心(解放军总医院)、国家老年疾病临床医学研究中心-老年心血管病防治联盟联合邀请高血压、神经认知领域的专家合作撰写本共识。旨在通过对当前国内外相关研究和文献的汇总分析,指导相关学科对老年高血压合并认知障碍的早期筛查、及时转诊、个性化综合干预,推动并积累我国的循证研究证据。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=老年高血压合并认知障碍诊疗中国专家共识_2021版_胡亦新.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6c3d41c00209890d, title=老年高血压合并认知障碍诊疗中国专家共识(2021 版), enTitle=, guiderFrom=中国心血管杂志.2021.26(2):101-111., authorId=0, author=, summary=为减少老年高血压合并认知障碍的风险,中国老年医学学会、中国老年医学学会高血压分会和认知障碍分会、国家老年疾病临床医学研究中心(解放军总医院)、国家老年疾病临床医学研究中心-老年心血管病防治联盟联合邀请, cover=https://img.medsci.cn/2021517/1621184750127_2020535.jpg, journalId=0, articlesId=null, associationId=1853, associationName=中国老年医学学会, associationIntro= , copyright=0, guiderPublishedTime=Sun Apr 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>为减少老年高血压合并认知障碍的风险,中国老年医学学会、中国老年医学学会高血压分会和认知障碍分会、国家老年疾病临床医学研究中心(解放军总医院)、国家老年疾病临床医学研究中心-老年心血管病防治联盟联合邀请高血压、神经认知领域的专家合作撰写本共识。旨在通过对当前国内外相关研究和文献的汇总分析,指导相关学科对老年高血压合并认知障碍的早期筛查、及时转诊、个性化综合干预,推动并积累我国的循证研究证据。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1465, tagName=认知障碍)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1465, guiderKeyword=认知障碍, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8779, appHits=386, showAppHits=0, pcHits=584, showPcHits=8393, likes=1, shares=41, comments=25, approvalStatus=1, publishedTime=Mon May 17 01:10:39 CST 2021, publishedTimeString=2021-04-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon May 17 01:05:59 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 13:23:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=老年高血压合并认知障碍诊疗中国专家共识_2021版_胡亦新.pdf)])
老年高血压合并认知障碍诊疗中国专家共识_2021版_胡亦新.pdf
下载请点击:
评论区 (19)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2091158, encodeId=91ca20911583f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb595551149, createdName=ms3000000908223949, createdTime=Fri Sep 30 10:19:11 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220965, encodeId=37011220965ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76eb5616431, createdName=ms4000000210557398, createdTime=Thu May 19 16:41:52 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196449, encodeId=76811196449d9, content=非常适用,好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9862506027, createdName=124ac591m88(暂无昵称), createdTime=Wed Feb 23 15:49:35 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058764, encodeId=b1541058e6404, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d45614521, createdName=老毛病, createdTime=Fri Oct 08 23:41:39 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012954, encodeId=e14c10129543d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/1b78d61bf1164c5fb7d2adc95ea3502f/c3fd00bf5162442c86c07627abc5587d.jpg, createdBy=a0555557408, createdName=ms1000000448217959, createdTime=Mon Aug 30 19:07:10 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
    2022-09-30 ms3000000908223949

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2091158, encodeId=91ca20911583f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb595551149, createdName=ms3000000908223949, createdTime=Fri Sep 30 10:19:11 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220965, encodeId=37011220965ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76eb5616431, createdName=ms4000000210557398, createdTime=Thu May 19 16:41:52 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196449, encodeId=76811196449d9, content=非常适用,好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9862506027, createdName=124ac591m88(暂无昵称), createdTime=Wed Feb 23 15:49:35 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058764, encodeId=b1541058e6404, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d45614521, createdName=老毛病, createdTime=Fri Oct 08 23:41:39 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012954, encodeId=e14c10129543d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/1b78d61bf1164c5fb7d2adc95ea3502f/c3fd00bf5162442c86c07627abc5587d.jpg, createdBy=a0555557408, createdName=ms1000000448217959, createdTime=Mon Aug 30 19:07:10 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
    2022-05-19 ms4000000210557398

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2091158, encodeId=91ca20911583f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb595551149, createdName=ms3000000908223949, createdTime=Fri Sep 30 10:19:11 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220965, encodeId=37011220965ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76eb5616431, createdName=ms4000000210557398, createdTime=Thu May 19 16:41:52 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196449, encodeId=76811196449d9, content=非常适用,好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9862506027, createdName=124ac591m88(暂无昵称), createdTime=Wed Feb 23 15:49:35 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058764, encodeId=b1541058e6404, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d45614521, createdName=老毛病, createdTime=Fri Oct 08 23:41:39 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012954, encodeId=e14c10129543d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/1b78d61bf1164c5fb7d2adc95ea3502f/c3fd00bf5162442c86c07627abc5587d.jpg, createdBy=a0555557408, createdName=ms1000000448217959, createdTime=Mon Aug 30 19:07:10 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
    2022-02-23 124ac591m88(暂无昵称)

    非常适用,好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2091158, encodeId=91ca20911583f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb595551149, createdName=ms3000000908223949, createdTime=Fri Sep 30 10:19:11 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220965, encodeId=37011220965ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76eb5616431, createdName=ms4000000210557398, createdTime=Thu May 19 16:41:52 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196449, encodeId=76811196449d9, content=非常适用,好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9862506027, createdName=124ac591m88(暂无昵称), createdTime=Wed Feb 23 15:49:35 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058764, encodeId=b1541058e6404, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d45614521, createdName=老毛病, createdTime=Fri Oct 08 23:41:39 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012954, encodeId=e14c10129543d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/1b78d61bf1164c5fb7d2adc95ea3502f/c3fd00bf5162442c86c07627abc5587d.jpg, createdBy=a0555557408, createdName=ms1000000448217959, createdTime=Mon Aug 30 19:07:10 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
    2021-10-08 老毛病

    可以

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2091158, encodeId=91ca20911583f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb595551149, createdName=ms3000000908223949, createdTime=Fri Sep 30 10:19:11 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220965, encodeId=37011220965ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76eb5616431, createdName=ms4000000210557398, createdTime=Thu May 19 16:41:52 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196449, encodeId=76811196449d9, content=非常适用,好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9862506027, createdName=124ac591m88(暂无昵称), createdTime=Wed Feb 23 15:49:35 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058764, encodeId=b1541058e6404, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d45614521, createdName=老毛病, createdTime=Fri Oct 08 23:41:39 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012954, encodeId=e14c10129543d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/1b78d61bf1164c5fb7d2adc95ea3502f/c3fd00bf5162442c86c07627abc5587d.jpg, createdBy=a0555557408, createdName=ms1000000448217959, createdTime=Mon Aug 30 19:07:10 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
    2021-08-30 ms1000000448217959

    0

拓展阅读

2011中华医学会 血管性认知障碍诊治指南

中华医学会神经病学分会 · 2011-01-01

中国痴呆与认知障碍诊治指南(二):痴呆分型及诊断标准

中华医学会神经病学分会痴呆与认知障碍学组 · 2011-03-08

中国痴呆与认知障碍诊治指南(一):痴呆诊断流程

中华医学会神经病学分会痴呆与认知障碍学组 · 2011-03-08